Royalty Pharma Plc (RPRX)
62.10
+0.77
(+1.26%)
USD |
NASDAQ |
Aug 25, 12:56
Royalty Pharma Total Liabilities (Quarterly) : 10.03B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.03B |
| March 31, 2026 | 9.879B |
| December 31, 2025 | 9.906B |
| September 30, 2025 | 9.726B |
| June 30, 2025 | 8.820B |
| March 31, 2025 | 7.820B |
| December 31, 2024 | 7.880B |
| September 30, 2024 | 7.784B |
| June 30, 2024 | 7.905B |
| March 31, 2024 | 6.267B |
| December 31, 2023 | 6.298B |
| September 30, 2023 | 6.270B |
| June 30, 2023 | 7.308B |
| March 31, 2023 | 7.252B |
| Date | Value |
|---|---|
| December 31, 2022 | 7.288B |
| September 30, 2022 | 7.256B |
| June 30, 2022 | 7.332B |
| March 31, 2022 | 7.237B |
| December 31, 2021 | 7.267B |
| September 30, 2021 | 7.346B |
| June 30, 2021 | 6.110B |
| March 31, 2021 | 6.077B |
| December 31, 2020 | 6.124B |
| September 30, 2020 | 6.192B |
| June 30, 2020 | 6.291B |
| March 31, 2020 | 6.209B |
| December 31, 2019 | 6.308B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 66.63B |
| Johnson & Johnson | 116.09B |
| Viatris, Inc. | 20.78B |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.82B |
| Shareholders Equity (Quarterly) | 6.833B |
| Debt to Equity Ratio | 1.312 |
| Current Ratio | 2.797 |
| Net Debt Paydown Yield | -1.08% |